Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Algernon Pharmaceuticalsinc
(CSE:
AGN
)
0.1150
-0.0050 (-4.17%)
Streaming Delayed Price
Updated: 3:11 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Algernon Pharmaceuticalsinc
< Previous
1
2
3
Next >
Hyperhidrosis Treatment Market Projected to Show Strong Growth: Dermira, Revance Therapeutics, Ulthera, TheraVida
March 10, 2023
Get an extensive Hyperhidrosis Treatment Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry.
Via
SBWire
Jessie Poole Nominated As 2023 National Trainer For CoolSculpting
March 02, 2023
Via
Press Release Distribution Service
Anti-aging Services Market May See a Big Move : Allergan, Beiersdorf, Cutera
February 13, 2023
Stay up-to-date with Anti-aging Services Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Tissue Engineering Market Next Big Thing : Major Giants- Allergan, Biotime, B. Braun
February 13, 2023
Stay up-to-date with Tissue Engineering Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Europe Infusion Therapy Market Is Expected to Grow at a CAGR of 7.2% During the Forecast Period 2023-2030
February 09, 2023
The Europe Infusion Therapy market size was valued at US$ 11,069.73 million in 2022 and is estimated to reach US$ 19,152.54 million by 2030, growing at a CAGR of 7.2% during the forecast period...
Via
SBWire
Is the Pain Over for Baudax Bio Investors after a 70% Spike?
January 25, 2023
Baudax Bio (NASDAQ: BXRX) shares spiked as much as 70% on its announcement of positive interim phase 2 clinical trials for its pain medicine BX1000.
Via
MarketBeat
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Pharmaceutical Expert as New Strategic Advisor
January 23, 2023
Via
CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Pharmaceutical Expert as New Strategic Advisor
January 23, 2023
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
The Power Play by The Market Herald Releases a New Interview with Algernon Pharmaceuticals Discussing Their Latest News
January 09, 2023
Via
ACCESSWIRE
Irritable Bowel Syndrome Treatment Market 2022 Treatment Analysis, Outlook, Research and SWOT Analysis by Key Players - Allergan Plc, Synergy Pharmaceuticals, Inc, Abbott
November 28, 2022
A disordered bowel movement in irritable bowel syndrome is characterized by abdominal pain and altered behaviour. It impairs the natural progression of intestinal muscle linings while eating to move...
Via
SBWire
Lemont Medspa Expands Services And Service Area
November 11, 2022
Via
Get News
Algernon Pharmaceuticals: Advancing DMT into a Phase 1 Clinical Trial, CEO Clips Video
November 08, 2022
Vancouver, British Columbia--(Newsfile Corp. - November 8, 2022) - Algernon Pharmaceuticals (CSE: AGN) (OTCQB: AGNPF) – The company is focused on...
Via
Newsfile
Drug Repurposing Market to Eyewitness Huge Growth by 2027 : Allergan, Astellas Pharma, Biovista, NuMedii
November 07, 2022
Stay up-to-date with Drug Repurposing Market research offered by AMA. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Exposures
Product Safety
As Sales of Botox and Juvederm Begin to Stall, the Abbvie Stock Price Drops
October 28, 2022
AbbVie Inc (NYSE:ABBV) AbbVie Inc (NYSE:ABBV) quarterly sales were below Wall Street’s expectations on Friday, primarily due to lower-than-anticipated income from its popular cosmetic filler Juvederm...
Via
PressReach
Topics
Economy
Exposures
Economy
Interest Rates
Eyelashes Enhancing Agents Market to See Major Growth by 2027 : Estee Lauder, Athena, Allergan
October 14, 2022
How customers and prospects view your existing business and products, benchmark view point to know if it is matching customers’ needs or not. Know possibility and uncover untapped opinions of Eyelashes...
Via
SBWire
Global Botox Market Size to Surpass US$ 8231.4 Million by 2027
October 13, 2022
Botox Market- The new report offers a powerful combination of the latest, in-depth research studies on the global Botox market. The authors of the report are highly experienced analysts and possess...
Via
SBWire
Global Eye Drops & Lubricants Market Size to Surpass US$ 9824.7 Million by 2027
October 13, 2022
Eye Drops & Lubricants Market: The authors of the report have deeply researched about key areas of the global Eye Drops & Lubricants market and provided verified market findings and reliable...
Via
SBWire
Dr Ash Labib Recognised for championing the Non-Surgical Rhinoplasty procedure
October 04, 2022
Via
AB Newswire
How Katie Sowden Became The Cosmetic Nurse of Queensland
September 28, 2022
Via
Get News
Autologous Fat Grafting Market Size 2022 : Global Demand Analysis, Growth Status, Strategic Assessment and Feasibility Study by 2028
September 08, 2022
Autologous Fat Grafting Market 2022-2028 | Major Key Players included in this Report are Sterimedix Ltd , Ranfac Corp , Allergan plc. and Many More with SWOT Analysis by 2028
Via
SBWire
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints New Board Member
September 02, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints New Board Member
September 02, 2022
Via
CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
The Power Play by The Market Herald Releases New Interviews with Algernon, Permex Petroleum, Infinity Stone, Green River Gold, HIRE Technologies, and Aton Resources Discussing Their Latest News
September 01, 2022
Via
ACCESSWIRE
Worldwide Acne Treatment Market Is Projected to Reach About USD 8.69 Billion by 2028, with a CAGR of 5.1%
August 30, 2022
Acne Treatment Market SWOT Analysis Including Key Players Allergan plc, Almirall, S.A., Bausch Health Companies Inc., F. Hoffmann-la Roche Ltd., Galderma S.A. (Nestle S.A.), GlaxoSmithKline Plc (GSK),...
Via
SBWire
The Power Play by The Market Herald Releases New Interviews with First Mining Gold Corp., Algernon Pharmaceuticals, G Mining Ventures, ApartmentLove, and Orvana Minerals
July 18, 2022
VANCOUVER, BC / ACCESSWIRE / July 18, 2022 / The Power Play by The Market Herald has announced the release of new interviews with First Mining Gold Corp., Algernon Pharmaceuticals, G Mining Ventures,...
From
The Market Herald
Via
AccessWire
The Power Play by The Market Herald Releases New Interviews with K9 Gold, Algernon Pharmaceuticals, Deep-South Resources, and Saturn Oil & Gas
July 07, 2022
VANCOUVER, BC / ACCESSWIRE / July 7, 2022 / The Power Play by The Market Herald has announced the release of new interviews with K9 Gold, Algernon Pharmaceuticals, Deep-South Resources, and Saturn Oil...
From
The Market Herald
Via
AccessWire
Dry Eye Syndrome Treatment Market Size, Share, Key Players Analysis, Growth Factors, New Technology, Application and Regional Forecast to 2028
July 06, 2022
Global Dry Eye Syndrome Treatment Market Size was estimated at USD 3062.77 million in 2021 and is projected to reach USD 3959.59 million by 2028, exhibiting a CAGR of 3.74% during the forecast period
Via
SBWire
Dystonia Zoo Days Start August 18
July 05, 2022
In-Person & Virtual Events Connect Dystonia Patients & Support Research toward a CureCHICAGO - July 5, 2022 - PRLog -- The Dystonia Medical Research Foundation (DMRF) is hosting a season of events to...
Via
PRLog
Exposures
COVID-19
Wilmington Dermatology Center Adds Second Allergan National Trainer
June 23, 2022
Via
Press Release Distribution Service
Sirona Biochem Brings In Former Bayer Executive Following AbbVie Deal
June 20, 2022
Sirona Biochem Corp. (TSX-V: SBM) is tapping into the 30 years of experience of former Bayer executive Dr. Wolfgang Bieber to help bring the company to the next level. The appointment comes just days...
Via
PRLog
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.